Immune Checkpoint Inhibitor‐induced Type 1 Diabetes: A Systematic Review and Meta‐analysis

Diabetic Medicine - United Kingdom
doi 10.1111/dme.14050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Mayo Clinic Proceedings
Medicine
2020English

Immune Checkpoint Inhibitors and Type 1 Diabetes Mellitus: A Case Report and Systematic Review

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Associated Auto-Immune Disease in Type 1 Diabetes Patients: A Systematic Review and Meta-Analysis.

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies

Frontiers in Pharmacology
Pharmacology
2019English

P3.04-18 the Efficacy and Safety of Solid Tumors Combination Therapy With Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
2020English

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review

Internal Medicine
Internal MedicineMedicine
2019English

Association of Puberty Timing With Type 2 Diabetes: A Systematic Review and Meta-Analysis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2020English

Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis

Nutrients
NutritionFood ScienceDietetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy